Alex holds an MEng in Civil Engineering from the University of Bristol and is a CFA Charterholder.

Alex joined Intermede in December 2024. He previously worked at Railpen as an Investment Manager on their Fundamental Equities team, focusing on global healthcare across public equities and late-stage venture (2021-2024). Before that, Alex was an Equity Research Analyst at Morgan Stanley (2016-2021) and Barclays (2014-2016), specializing in Medical Technology.